Gammagard S/D
NOTE: Takeda is discontinuing Gammagard S/D in December 2027.
Administration: IVIG
Concentration: 5% (50 mg/mL) or 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Gammagard Liquid
Administration: IVIG or SCIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Flebogamma DIF
Administration: IVIG
Concentration: 5% (50 mg/mL) or 10% (100 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at https://www.grifols.com/en/notification-of-adverse-reaction.
Cuvitru
Administration: SCIG
Concentration: 20% (200 mg/mL)
Approved for: Ages 2+
Report side effects/adverse reactions at pvsafetyamericas@takeda.com or 1-877-825-3327.
Cutaquig
Administration: SCIG
Concentration: 16.5% (165 mg/mL)
Approved for: Ages 2+
Octapharma and Pfizer both distribute Cutaquig. Each company has its own product website and may have its own copay assistance program. If your infusion center or hospital supplies Cutaquig, it is typically distributed by Octapharma. If you get Cutaquig through a specialty pharmacy/for home care, it is distributed by Pfizer.
Report side effects/adverse reactions at 201-604-1137.
Biotest AG
Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs.
Kedrion
At Kedrion Biopharma, our mission is to enhance lives through our work in the field of rare and ultra-rare diseases. We are committed to collecting plasma and producing plasma-derived therapies that treat and prevent rare and debilitating conditions such as Coagulation and Neurological Disorders, Immunodeficiencies, and Rh sensitization.
Sobi
At Sobi North America, we are inspired by a single vision – to be recognized as a global leader in providing innovative medicines that transform the lives of people with rare and debilitating diseases.
GC Biopharma
GC Biopharma, the top pharmaceutical manufacturer of plasma products in Asia, is among the largest worldwide, distributing to more than 50 countries.
Takeda
We are a global, values-based, R&D-driven biopharmaceutical leader with a large U.S. presence. We aim to discover and deliver lifetransforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
